261 results
Page 5 of 14
424B3
1tl0z4ez wowssqy
11 Aug 21
Prospectus supplement
4:34pm
8-K
i38mu63
11 Aug 21
GeoVax Reports 2021 Second Quarter Financial Results
4:30pm
POS AM
8cr mi0cj
24 Mar 21
Prospectus update (post-effective amendment)
9:17am
8-K
EX-99.1
ohdamgvg 1975yd
23 Mar 21
GeoVax Reports 2020 Year-End Financial Results
4:35pm
D
80jimde6936j
25 Feb 21
$495K in equity / options, sold $495K, 1 investor
12:00am
8-K
EX-1.01
yh1w05 np9
11 Feb 21
GeoVax Announces Pricing of $9.0 Million Bought Deal Offering
9:21am
424B5
bhs2avs3te18qlz
11 Feb 21
Prospectus supplement for primary offering
9:17am
8-K
EX-99.1
m96onw9f0gd47w5c1
30 Nov 20
GeoVax Announces License Agreement with NIH to Support Continued Advancements in Vaccine Development
5:18pm
8-K
ybtlhxes8ijw q8uz
30 Nov 20
GeoVax Announces License Agreement with NIH to Support Continued Advancements in Vaccine Development
5:18pm
8-K
EX-10.1
01ul xxsxx3wq04s
30 Nov 20
GeoVax Announces License Agreement with NIH to Support Continued Advancements in Vaccine Development
5:18pm
424B3
d312 kq6ivrr2r94d
5 Nov 20
Prospectus supplement
5:17pm
8-K
EX-99.1
h4jygded r4078s3etwa
26 Oct 20
GeoVax Announces License Agreement with NIH
5:28pm
8-K
3g78ihw on
26 Oct 20
GeoVax Announces License Agreement with NIH
5:28pm
8-K
EX-10.1
j1u81en0cg4 7xmx
26 Oct 20
GeoVax Announces License Agreement with NIH
5:28pm